Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02825875 · ClinicalTrials.gov registry record
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer
A clinical trial, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- 200
- Enrollment target
NCT02825875 is a clinical trial that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 200 participants.
The verdict
NCT02825875 has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
In this study we aim to more precisely define the clinical utility of PSMA imaging across a range of clinical indications in men with prostate cancer. To accomplish this, we will make the 18F-DCFPyL PET/CT scan available to urologists, medical oncologists, and radiation oncologists at Johns Hopkins and survey physicians as to the indication for ordering the PET/CT and if a change in management occurred as the result of new information gained from the scan. We believe these data will prove critical for planning future studies aimed at evaluating the efficacy of this test for improving patient outcomes.
Interventions
- DRUG 18F DCFPyL- Radiopharmaceutica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-06-08 |
| Est. Completion | 2020-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02825875
The ClinicalTrials.gov registry entry for NCT02825875 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 18F DCFPyL- Radiopharmaceutica is the first listed.
NCT02825875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02825875 about?
NCT02825875 is a clinical study titled "Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer". In this study we aim to more precisely define the clinical utility of PSMA imaging across a range of clinical indications in men with prostate cancer. To accomplish this, we will make the 18F-DCFPyL PET/CT scan available to urologists, medical oncologists, and radiation oncologists at Johns Hopkins ...
What is the current status of trial NCT02825875?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2016-06-08. Estimated completion is 2020-04.
What interventions are being tested in trial NCT02825875?
The interventions under investigation include: 18F DCFPyL- Radiopharmaceutica (DRUG).
Who is sponsoring clinical trial NCT02825875?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.